Royal Philips in Polish bribery probe; CryoLife completes Cardiogenesis buy;

>  Royal Philips Electronics NV is being probed for alleged bribery in Poland, Het Financieele Dagblad says. Hospital directors may have been offered money in exchange for ordering Philips medical equipment, the newspaper reported. Item

> CryoLife has successfully completed its acquisition of Cardiogenesis Corporation. CryoLife release

> Paulson & Co., once Boston Scientific's largest shareholder, continued to liquidate its position in the devicemaker during the first quarter, selling off some 10 million shares from its stake in the company. News

> Medtronic has launched the Kyphon Xpede bone cement, a quick-to-dough polymethylmethacrylate bone cement for use in the treatment of spinal fractures with minimally invasive Kyphon Balloon Kyphoplasty in the U.S. Medtronic release

> Zimmer Holdings has launched a new, comprehensive range of Trabecular Metal Material augment shapes and cones for use in knee revision surgeries. Zimmer release

> Oraya Therapeutics has completed enrollment of its INTREPID clinical trial in Europe. The study is evaluating the effectiveness and safety of radiation therapy in conjunction with standard of care anti-VEGF injections for the treatment of wet age-related macular degeneration. The IRay treatment is a one-time non-surgical procedure which may significantly reduce or eliminate the need for subsequent anti-VEGF injections, while maintaining or improving vision outcomes in treated patients. Oraya release

>  A Salalah, Oman-based manufacturer of medical guidewires is set to supply the U.S. and the EU following its fourth regulatory endorsement in two years. Report

And Finally... The Tijuana Economic Development Council recently published a White Paper highlighting an annual growth of 8.7 percent in employment of the medical device sector since 2004, reaching more than 30,000 workers, concentrated in 40 medical manufacturing companies, including Care Fusion, Medtronic, DJO Global and GreatBatch. This number outpaces the Minneapolis/Saint Paul metro region. Tijuana EDC release

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.